184 related articles for article (PubMed ID: 34025392)
1. Probiotic Supplementation Facilitates Recovery of 6-OHDA-Induced Motor Deficit via Improving Mitochondrial Function and Energy Metabolism.
Nurrahma BA; Tsao SP; Wu CH; Yeh TH; Hsieh PS; Panunggal B; Huang HY
Front Aging Neurosci; 2021; 13():668775. PubMed ID: 34025392
[TBL] [Abstract][Full Text] [Related]
2. Probiotic Enhancement of Antioxidant Capacity and Alterations of Gut Microbiota Composition in 6-Hydroxydopamin-Induced Parkinson's Disease Rats.
Tsao SP; Nurrahma BA; Kumar R; Wu CH; Yeh TH; Chiu CC; Lee YP; Liao YC; Huang CH; Yeh YT; Huang HY
Antioxidants (Basel); 2021 Nov; 10(11):. PubMed ID: 34829694
[TBL] [Abstract][Full Text] [Related]
3. Mangosteen Pericarp Extract Supplementation Boosts Antioxidant Status via Rebuilding Gut Microbiota to Attenuate Motor Deficit in 6-OHDA-Induced Parkinson's Disease.
Nurrahma BA; Yeh TH; Hsieh RH; Tsao SP; Chen CW; Lee YP; Pan CH; Huang HY
Antioxidants (Basel); 2022 Dec; 11(12):. PubMed ID: 36552604
[TBL] [Abstract][Full Text] [Related]
4. Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease.
Koutzoumis DN; Vergara M; Pino J; Buddendorff J; Khoshbouei H; Mandel RJ; Torres GE
Exp Neurol; 2020 Mar; 325():113159. PubMed ID: 31843492
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of the Combination of Probiotic Supplementation on Motor Symptoms and Constipation in Parkinson's Disease.
Alexoudi A; Kesidou L; Gatzonis S; Charalampopoulos C; Tsoga A
Cureus; 2023 Nov; 15(11):e49320. PubMed ID: 38146566
[TBL] [Abstract][Full Text] [Related]
6. Alpha Lipoamide Ameliorates Motor Deficits and Mitochondrial Dynamics in the Parkinson's Disease Model Induced by 6-Hydroxydopamine.
Zhou B; Wen M; Lin X; Chen YH; Gou Y; Li Y; Zhang Y; Li HW; Tang L
Neurotox Res; 2018 May; 33(4):759-767. PubMed ID: 29019159
[TBL] [Abstract][Full Text] [Related]
7. Rebamipide Mitigates Impairments in Mitochondrial Function and Bioenergetics with α-Synuclein Pathology in 6-OHDA-Induced Hemiparkinson's Model in Rats.
Mishra A; Krishnamurthy S
Neurotox Res; 2019 Apr; 35(3):542-562. PubMed ID: 30610666
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D1 receptor agonism induces dynamin related protein-1 inhibition to improve mitochondrial biogenesis and dopaminergic neurogenesis in rat model of Parkinson's disease.
Mishra A; Singh S; Tiwari V; Bano S; Shukla S
Behav Brain Res; 2020 Jan; 378():112304. PubMed ID: 31626851
[TBL] [Abstract][Full Text] [Related]
9. Involvement of BDNF/TrkB signaling in the effect of diphenyl diselenide on motor function in a Parkinson's disease rat model.
Sampaio TB; Pinton S; da Rocha JT; Gai BM; Nogueira CW
Eur J Pharmacol; 2017 Jan; 795():28-35. PubMed ID: 27915043
[TBL] [Abstract][Full Text] [Related]
10. Hypertension Programmed by Perinatal High-Fat Diet: Effect of Maternal Gut Microbiota-Targeted Therapy.
Hsu CN; Hou CY; Chan JYH; Lee CT; Tain YL
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31810197
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
12. 6-Hydroxydopamine induces different mitochondrial bioenergetics response in brain regions of rat.
Gonçalves DF; Courtes AA; Hartmann DD; da Rosa PC; Oliveira DM; Soares FAA; Dalla Corte CL
Neurotoxicology; 2019 Jan; 70():1-11. PubMed ID: 30359634
[TBL] [Abstract][Full Text] [Related]
13. Dopamine receptor activation mitigates mitochondrial dysfunction and oxidative stress to enhance dopaminergic neurogenesis in 6-OHDA lesioned rats: A role of Wnt signalling.
Mishra A; Singh S; Tiwari V; Chaturvedi S; Wahajuddin M; Shukla S
Neurochem Int; 2019 Oct; 129():104463. PubMed ID: 31078578
[TBL] [Abstract][Full Text] [Related]
14. Tetramethylpyrazine Analogue T-006 Exerts Neuroprotective Effects against 6-Hydroxydopamine-Induced Parkinson's Disease
Zhou H; Shao M; Yang X; Li C; Cui G; Gao C; Di L; Zhong H; Wang Y; Zhang Z; Lee SM
Oxid Med Cell Longev; 2019; 2019():8169125. PubMed ID: 31827703
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of the beneficial effect of melatonin in experimental Parkinson's disease.
Yildirim FB; Ozsoy O; Tanriover G; Kaya Y; Ogut E; Gemici B; Dilmac S; Ozkan A; Agar A; Aslan M
Neurochem Int; 2014 Dec; 79():1-11. PubMed ID: 25263280
[TBL] [Abstract][Full Text] [Related]
16. Influence of probiotic bacteria on gut microbiota composition and gut wall function in an
Ghyselinck J; Verstrepen L; Moens F; Van Den Abbeele P; Bruggeman A; Said J; Smith B; Barker LA; Jordan C; Leta V; Chaudhuri KR; Basit AW; Gaisford S
Int J Pharm X; 2021 Dec; 3():100087. PubMed ID: 34977556
[TBL] [Abstract][Full Text] [Related]
17. Polylysine-modified polyethylenimine (PEI-PLL) mediated VEGF gene delivery protects dopaminergic neurons in cell culture and in rat models of Parkinson's Disease (PD).
Sheikh MA; Malik YS; Xing Z; Guo Z; Tian H; Zhu X; Chen X
Acta Biomater; 2017 May; 54():58-68. PubMed ID: 28025049
[TBL] [Abstract][Full Text] [Related]
18. Echinacoside Protects against 6-Hydroxydopamine-Induced Mitochondrial Dysfunction and Inflammatory Responses in PC12 Cells via Reducing ROS Production.
Wang YH; Xuan ZH; Tian S; Du GH
Evid Based Complement Alternat Med; 2015; 2015():189239. PubMed ID: 25788961
[TBL] [Abstract][Full Text] [Related]
19. Guanosine Protects Striatal Slices Against 6-OHDA-Induced Oxidative Damage, Mitochondrial Dysfunction, and ATP Depletion.
Marques NF; Massari CM; Tasca CI
Neurotox Res; 2019 Feb; 35(2):475-483. PubMed ID: 30417317
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
